STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Quipt Home Medical to Participate at the Sidoti Virtual Investor Conference on June 23rd – 24th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Quipt Home Medical Corp. (NASDAQ:QIPT; TSXV:QIPT) announced a webcasted presentation on June 24, 2021, during the Sidoti Virtual Investor Conference.

The live event will commence at 9:15 AM ET, aimed at sharing the company's growth story and plans to expand its shareholder base following its Nasdaq listing. CEO Greg Crawford expressed optimism about their acquisition pipeline and the potential for strong growth in the second half of the year.

Quipt provides in-home monitoring and chronic disease management services, primarily focusing on respiratory care.

Positive
  • None.
Negative
  • None.

Sidoti Webcasted Presentation to be Held Thursday, June 24th

CINCINNATI, June 10, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that members of its management team will host a webcasted presentation and participate in 1x1 meetings at the upcoming Sidoti Virtual Investor Conference on June 23rd – 24th.

Webcasted Presentation

Event:Sidoti Virtual Investor Conference
Date: Thursday, June 24, 2021
Time:9:15am (ET)

The live webcast of the presentation will be available by visiting the investors' section of the Company’s website at www.Quipthomemedical.com. The webcast will also be available for replay on the Company's website following the event.

“With the successful completion of our Nasdaq listing behind us, now is the time for us to be active in sharing the exciting Quipt story with U.S. based investors in order to expand our shareholder base. With the most advantageous regulatory landscape in a decade, continued operating momentum, and strong organic growth, we could not be more bullish about the outlook for our company. Furthermore, we have a full pipeline of acquisition targets including larger opportunities that would provide us the ability to have a very active second half of the year,” commented Greg Crawford, CEO, and Chairman of Quipt.

ABOUT QUIPT HOME MEDICAL

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

There can be no assurance that any acquisitions will be completed or the timing of any acquisitions.‎

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of ‎the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.‎

Forward-Looking Statements

Certain statements contained in this press release constitute "forward-looking information" as such term is ‎‎‎defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", ‎‎‎‎"will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate ‎‎‎to the Company, including: the Company’s acquisition plans and potentially completing acquisitions; are intended to identify ‎forward-looking information. All statements other than ‎statements of ‎historical fact may be forward-looking ‎information. Such statements reflect the Company's current ‎views and ‎intentions with respect to future events, and ‎current information available to the Company, and are ‎subject to ‎certain risks, uncertainties and assumptions, ‎including, without limitation: the Company successfully identifying, negotiating and completing one or more ‎acquisitions, including conditions precedent for such acquisitions being satisfied. Many factors ‎could ‎cause the actual results, performance or achievements that may be expressed or ‎implied by such forward-‎looking ‎information to vary from those described herein should one or more of these risks ‎or uncertainties ‎materialize. ‎Examples of such risk factors include, without limitation: credit; market (including ‎equity, commodity, ‎foreign ‎exchange and interest rate); liquidity; operational (including technology and ‎infrastructure); ‎reputational; ‎insurance; strategic; regulatory; legal; environmental; capital adequacy; the ‎general business and ‎economic ‎conditions in the regions in which the Company operates; the ability of the ‎Company to execute on key ‎priorities, ‎including the successful completion of acquisitions, business retention, and ‎strategic plans and to ‎attract, develop ‎and retain key executives; difficulty integrating newly acquired businesses; ‎the ability to ‎implement business ‎strategies and pursue business opportunities; low profit market segments; ‎disruptions in or ‎attacks (including ‎cyber-attacks) on the Company's information technology, internet, network ‎access or other ‎voice or data ‎communications systems or services; the evolution of various types of fraud or other ‎criminal ‎behavior to which ‎the Company is exposed; the failure of third parties to comply with their obligations to ‎the ‎Company or its ‎affiliates; the impact of new and changes to, or application of, current laws and regulations; ‎‎decline of ‎reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model; ‎‎‎dependence on key suppliers; granting of permits and licenses in a highly regulated business; the overall difficult ‎‎‎litigation environment, including in the U.S.; increased competition; changes in foreign currency rates; increased ‎‎‎funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds ‎‎‎and resources to pursue operations; critical accounting estimates and changes to accounting standards, policies, ‎‎‎and methods used by the Company; the occurrence of natural and unnatural catastrophic events ‎and claims ‎‎‎resulting from such events; and risks related to COVID-19 including various recommendations, orders ‎and ‎‎measures of governmental ‎authorities ‎to try to limit the pandemic, including travel restrictions, border closures, ‎‎‎non-essential business ‎closures, ‎quarantines, self-isolations, shelters-in-place and social distancing, disruptions ‎‎to ‎markets, economic ‎activity, ‎financing, supply chains and sales channels, and a deterioration of general ‎‎economic ‎conditions ‎including a ‎possible national or global recession‎; as well as those risk factors discussed or ‎‎referred to in ‎the Company’s disclosure ‎documents filed with the securities regulatory authorities in certain ‎‎provinces of Canada ‎and available at ‎www.sedar.com. Should any factor affect the Company in an unexpected ‎‎manner, or should ‎assumptions ‎underlying the forward-looking information prove incorrect, the actual results or ‎‎events may differ ‎materially ‎from the results or events predicted. Any such forward-looking information is ‎‎expressly qualified in its ‎entirety by ‎this cautionary statement. Moreover, the Company does not assume ‎‎responsibility for the accuracy or ‎‎completeness of such forward-looking information. The forward-looking ‎‎information included in this press release ‎is ‎made as of the date of this press release and the Company undertakes ‎‎no obligation to publicly update or revise ‎any ‎forward-looking information, other than as required by applicable ‎‎law.‎‎

For further information please visit our website at www.Quipthomemedical.com, or contact:

Cole Stevens
VP of Corporate Development
Quipt Home Medical Corp.
859-300-6455
cole.stevens@myquipt.com

Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com


FAQ

What is the date and time of Quipt Home Medical's webcasted presentation?

The webcasted presentation will be held on June 24, 2021, at 9:15 AM ET.

Where can I watch the Quipt Home Medical presentation?

The live webcast can be viewed on Quipt Home Medical's website in the investor section.

What is the purpose of Quipt Home Medical's participation in the Sidoti conference?

Quipt aims to share its growth story with U.S. investors to expand its shareholder base following its recent Nasdaq listing.

What are Quipt's plans for the future according to the press release?

Quipt plans to pursue acquisitions and aims for strong organic growth in the second half of the year.

What services does Quipt Home Medical provide?

Quipt offers in-home monitoring and disease management services, particularly focusing on respiratory care for patients.

PTQQD

:PTQQD

PTQQD Rankings

PTQQD Latest News

PTQQD Stock Data